Human Genome Epidemiology Literature Finder
|
Records 1 - 13 (of 13 Records) |
| Query Trace: Myelodysplastic Syndromes and SETBP1[original query] |
|---|
| Somatic SETBP1 mutations in myeloid malignancies. Nature genetics 2013 Aug 45 (8): 942-6. Makishima Hideki, Yoshida Kenichi, Nguyen Nhu, Przychodzen Bartlomiej, Sanada Masashi, Okuno Yusuke, Ng Kwok Peng, Gudmundsson Kristbjorn O, Vishwakarma Bandana A, Jerez Andres, Gomez-Segui Ines, Takahashi Mariko, Shiraishi Yuichi, Nagata Yasunobu, Guinta Kathryn, Mori Hiraku, Sekeres Mikkael A, Chiba Kenichi, Tanaka Hiroko, Muramatsu Hideki, Sakaguchi Hirotoshi, Paquette Ronald L, McDevitt Michael A, Kojima Seiji, Saunthararajah Yogen, Miyano Satoru, Shih Lee-Yung, Du Yang, Ogawa Seishi, Maciejewski Jaroslaw |
| SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations. Leukemia 2013 Sep 27 (9): 1852-60. Meggendorfer M, Bacher U, Alpermann T, Haferlach C, Kern W, Gambacorti-Passerini C, Haferlach T, Schnittger |
| Predictors of survival in refractory anemia with ring sideroblasts and thrombocytosis (RARS-T) and the role of next-generation sequencing. American journal of hematology 2016 Feb . Patnaik Mrinal M, Lasho Terra L, Finke Christy M, Hanson Curtis A, King Rebecca L, Ketterling Rhett P, Gangat Naseema, Tefferi Ayal |
| Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R. American journal of hematology 2017 Sep . Tefferi Ayalew, Lasho Terra L, Patnaik Mrinal M, Saeed Lyla, Mudireddy Mythri, Idossa Dame, Finke Christy, Ketterling Rhett P, Pardanani Animesh, Gangat Nasee |
| Targeted next generation sequencing and identification of risk factors in World Health Organization defined atypical chronic myeloid leukemia. American journal of hematology 2017 Mar . Patnaik Mrinal M, Barraco Daniela, Lasho Terra L, Finke Christy M, Reichard Kaaren, Hoversten Katherine P, Ketterling Rhett P, Gangat Naseema, Tefferi Ayal |
| Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis. PloS one 2017 12 (2): e0171608. Shou Li-Hong, Cao Dan, Dong Xiao-Hui, Fang Qiu, Wu Ying, Zhang Yan, Fei Ju-Ping, Xu Bao-Li |
| [Features and clinical significance of gene mutations in patients with myelodysplastic syndromes with ring sideroblasts]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2020 6 41 (5): 379-386. Cai Y N, Xu Z F, Li B, Qin T J, Pan L J, Qu S Q, Hu N B, Liu D, Huang H J, Shi Z X, Zhang Y D, Xiao Z |
| Decoding Bone Marrow Fibrosis in Myelodysplastic Syndromes. Clinical lymphoma, myeloma & leukemia 2020 2 20 (5): 324-328. Melody Megan, Al Ali Najla, Zhang Ling, Ramadan Hanadi, Padron Eric, Sallman David, Sweet Kendra, Lancet Jeffrey, List Alan, Bennett John M, Komrokji Ra |
| Impact of clinical features, cytogenetics, genetic mutations, and methylation dynamics of CDKN2B and DLC-1 promoters on treatment response to azacitidine. Annals of hematology 2020 1 99 (3): 527-537. Martín Iván, Navarro Blanca, Serrano Alicia, Villamón Eva, Calabuig Marisa, Solano Carlos, Chaves Felipe Javier, Yagüe Nuria, Orts Maribel, Amat Paula, Fuentes Azahara, Seda Enrique, García Francisca, Hernández-Boluda Juan Carlos, Tormo M |
| Mutations in chronic myelomonocytic leukemia and their prognostic relevance. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2021 4 23 (9): 1731-1742. Jian J, Qiao Y, Li Y, Guo Y, Ma H, Liu |
| Genetic mutations associated with blood count abnormalities in myeloid neoplasms. Hematology (Amsterdam, Netherlands) 2022 6 27 (1): 765-771. Polprasert Chantana, Kongkiatkamon Sunisa, Niparuck Pimjai, Rattanathammethee Thanawat, Wudhikarn Kitsada, Chuncharunee Suporn, Kobbuaklee Sirorat, Suksusut Amornchai, Lanamtieng Theerin, Lawasut Panisinee, Asawapanumas Thiti, Bunworasate Udomsak, Rojnuckarin Ponlap |
| U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity. Blood cancer journal 2023 9 13 (1): 149. Talha Badar, Yenny A Moreno Vanegas, Ahmad Nanaa, James M Foran, Aref Al-Kali, Abhishek Mangaonkar, Hemant Murthy, Hassan B Alkhateeb, David Viswanatha, Rong He, Mithun Shah, Cecilia Arana Yi, Mark R Litzow, Naseema Gangat, Ayalew Tefferi, Mrinal M Patna |
| [Clinical features and prognostic factors of advanced myelodysplastic syndromes in children]. Zhonghua yi xue za zhi 2024 7 104 (27): 2529-2534. C M Liu, Y L Chen, X C Wang, X L Li, W B An, Y Wan, Y Y Ren, X Chen, F Liu, Y Guo, X J Chen, L Zhang, Y Zou, Y M Chen, J Li, X J Guo, X F Zhu, W Y Ya |
- Page last reviewed:Feb 1, 2024
- Content source: